Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2008
06/26/2008WO2008077086A1 Aminopyrimidines useful as inhibitors of protein kinases
06/26/2008WO2008077085A1 Brain-derived gonadotropins and cognition
06/26/2008WO2008077068A1 Method of providing pirfenidone therapy to a patient
06/26/2008WO2008077062A2 Suppression of stat3 reactivation after src kinase inhibition to treat cancer
06/26/2008WO2008077050A1 Adenosine derivatives as partial and full agonists of a1 adenosine receptors
06/26/2008WO2008077009A1 Calcilytic compounds
06/26/2008WO2008076964A1 Therapeutics for cancer using 3-bromopyruvate and other selective inhibitors of atp production
06/26/2008WO2008076954A2 Heterocycle compounds and methods of use thereof
06/26/2008WO2008076949A2 Quinazoline derivatives and methods of treatment
06/26/2008WO2008076918A2 Anti-cancer agents and androgen inhibition activity compound
06/26/2008WO2008076906A1 Use of gentian violet in treatment of atopic dermatitis
06/26/2008WO2008076900A1 Novel ginsenoside compounds, compositions, and methods of use
06/26/2008WO2008076883A2 Triazine derivatives and their therapeutical applications
06/26/2008WO2008076862A2 1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors
06/26/2008WO2008076860A1 4-imidazolyl-1,2,3,4-tetrahydroquinoline derivatives and their use as aldosterone/11-beta-hydroxylase inhibitors
06/26/2008WO2008076841A1 Pharmaceutical composition for reducing the risks associated with cardiovascular and cerebrovascular diseases
06/26/2008WO2008076826A1 Pyrophosphoramide alkylators
06/26/2008WO2008076810A2 Azabicyclic heterocycles as cannabinoid receptor modulators
06/26/2008WO2008076804A2 Method of treating intrauterine inflammation
06/26/2008WO2008076780A2 Amorphous valsartan and the production thereof
06/26/2008WO2008076767A1 Chemotherapeutic flavonoids, and syntheses thereof
06/26/2008WO2008076752A1 Benzimidazole trpv1 inhibitors
06/26/2008WO2008076705A1 Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer
06/26/2008WO2008076704A1 Imidazolidinonyl aminopyrimidine compounds for the treatment' of cancer
06/26/2008WO2008076703A1 Methods and compositions for treating gastrointestinal disorders
06/26/2008WO2008076685A2 Process for the preparation of piperazinyl and diazepanyl benzamide derivatives
06/26/2008WO2008076562A1 5- [4- (azetidin-3-yl0xy) -phenyl] -2-phenyl-5h-thiaz0l0 [5,4-c] pyridin-4-0ne derivatives and their use as mch receptor antagonists
06/26/2008WO2008076458A1 Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use
06/26/2008WO2008076446A1 Accelerated opiate dependence detoxification process
06/26/2008WO2008076443A2 Combination therapy for treating hepatitis c infections
06/26/2008WO2008076427A2 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
06/26/2008WO2008076417A1 (1r,6s)-2-azabicyclo[4.3.0] nonane-8,8-diphosphonic acid and its use in treating or preventing bone disorders, for example, osteoporosis or paget's disease
06/26/2008WO2008076415A1 Methods of using mek inhibitors
06/26/2008WO2008076394A1 Compositions and methods for the treatment of cancer
06/26/2008WO2008076373A1 Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
06/26/2008WO2008076356A1 Novel oxadiazole compounds
06/26/2008WO2008076348A1 Crystalline solid rasagiline base
06/26/2008WO2008076315A1 Tannate salt of rasagiline
06/26/2008WO2008076295A1 Method and compositions for improving pulmonary hypertension
06/26/2008WO2008076278A2 Methods of cancer treatment with igf1r inhibitors
06/26/2008WO2008076270A2 Sulfide, sulfoxide and sulfone chalcone analogues, derivatives thereof and therapeutic uses thereof
06/26/2008WO2008076269A2 MONOPHOSPHATES AS MUTUAL PRODRUGS OF MUSCARINIC RECEPTOR ANTAGONISTS AND β-AGONISTS FOR THE TREATMENT OF COPD AND CHRONIC BRONCHITIS
06/26/2008WO2008076265A1 MONOPHOSPHATES AS MUTUAL PRODRUGS OF ANTI-INFLAMMATORY SIGNAL TRANSDUCTION MODULATORS (AISTM'S) AND β-AGONISTS FOR THE TREATMENT OF PULMONARY INFLAMMATION AND BRONCHOCONSTRICTION
06/26/2008WO2008076261A2 Water-soluble phenicol prodrugs in a lipophilic vehicle system
06/26/2008WO2008076259A1 Water-soluble prodrugs of florfenicol and its analogs
06/26/2008WO2008076256A1 Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
06/26/2008WO2008076251A2 Biocidal composition and method for treating recirculating water systems
06/26/2008WO2008076247A2 Nitroderivatives as angiotensin ii receptor antagonists
06/26/2008WO2008076246A2 Nitroderivatives as angiotensin ii receptor antagonists
06/26/2008WO2008076245A2 Nitroderivatives as angiotensin ii receptor antagonists
06/26/2008WO2008076242A1 Amido-amine polymer compositions
06/26/2008WO2008076229A1 Atomoxetine formulations and associated methods
06/26/2008WO2008076225A2 Non-nucleoside reverse transcriptase inhibitors
06/26/2008WO2008076223A1 Non-nucleoside reverse transcriptase inhibitors
06/26/2008WO2008076156A2 Glms riboswitches, structure-based compound design with glms riboswitches, and methods and compositions for use of and with glms riboswitches
06/26/2008WO2008076143A1 Combination of igfr inhibitor and anti-cancer agent
06/26/2008WO2008076127A1 Inhibitory polynucleotide compositions and methods for treating cancer
06/26/2008WO2008076097A1 Laminates of acid polysaccharide films
06/26/2008WO2008076048A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders
06/26/2008WO2008076046A1 Novel 2-amino-5, 5-diaryl-imidazol-4-ones
06/26/2008WO2008076045A1 Novel 2-amino- 5-aryl-imidazol-4 -ones
06/26/2008WO2008076044A1 Novel 2-amino-5, 5-diaryl-imidazol-4-ones
06/26/2008WO2008076043A1 Novel 2-amino-5,5-diaryl-imidazol-4-ones
06/26/2008WO2008076042A1 Azetidinpiperazine derivatives that are neurokinin (nk) receptor antagonists and their use.
06/26/2008WO2008076041A1 Azetidinazabicyclo [3.2.1] octan derivatives that are neurokinin (nk) receptor antagonists and their use.
06/26/2008WO2008076000A1 Agent for treating acute intoxications and complication thereof
06/26/2008WO2008075997A1 Method for treating opioid withdrawal syndrome
06/26/2008WO2008075993A1 The use of diethylamine as analgesic in pharmaceutical preparations
06/26/2008WO2008075984A2 Tablet formulation including macrocyclic lactone and levamisole anthelmintic agents
06/26/2008WO2008075978A2 An extract
06/26/2008WO2008075930A1 Compositions of risedronate and vitamin d3
06/26/2008WO2008075796A1 Agent for promoting recovery from blood cell depletion
06/26/2008WO2008075793A1 Composition for promoting bioabsorption of flavonoid, food/beverage for promoting bioabsorption of flavonoid using the composition, and method for production of the food/beverage
06/26/2008WO2008075762A1 Sustained-release composition and method for producing the same
06/26/2008WO2008075757A1 N-hydroxyacrylamide compounds
06/26/2008WO2008075741A1 Therapeutic agent and prophylactic agent for diabetes
06/26/2008WO2008075736A1 Method for producing c-glycoside derivative and synthetic intermediate thereof
06/26/2008WO2008075735A1 Prophylactic or therapeutic agent for alopecia
06/26/2008WO2008075713A1 Marker for diagnosis of cancer, and target molecule for therapy
06/26/2008WO2008075706A1 Therapeutic agent for interstitial pneumonia
06/26/2008WO2008075665A1 Transdermally absorbable preparation and adhesive sheet for application to the skin
06/26/2008WO2008075649A1 Food or drink, quasi drug and medicinal composition for promoting hair growth and method of promoting hair growth
06/26/2008WO2008075528A1 Use of h. macrophylla tea
06/26/2008WO2008075466A1 Food and drink, quasi drug and pharmaceutical composition for promoting hair growth, and method for promoting hair growth
06/26/2008WO2008075462A1 Helicobacter pylori eradicating agent having inhibitory activity on gastric acid secretion
06/26/2008WO2008075376A1 Polymorphic forms of bortezomib and process for their preparation
06/26/2008WO2008075372A1 Controlled release dosage forms of zolpidem
06/26/2008WO2008075366A2 Novel conjugates of polyunsaturated fatty acids with amines and therapeutic uses thereof
06/26/2008WO2008075353A1 Sulfonamide derivatives with therapeutic indications
06/26/2008WO2008075342A1 Treatment of lung cancer
06/26/2008WO2008075330A1 Method for administration of pegylated liposomal doxorubicin
06/26/2008WO2008075321A2 Modified-release formulations of azabicyclo derivatives
06/26/2008WO2008075320A2 Antilipidemic pharmaceutical compositions and process for preparation thereof
06/26/2008WO2008075196A1 Benzimidazole derivatives
06/26/2008WO2008075173A2 Methods for treating podocyte-related disorders
06/26/2008WO2008075162A2 Selective mu opioid receptor antagonists for the treatment of female sexual dysfunction
06/26/2008WO2008075155A2 Carbonic anhydrase inhibitors derivatives
06/26/2008WO2008075152A1 1- [4- (sulfonyl) -phenyl] -5- (benzyl) -ih-i, 2, 4-triazol derivatives as inhibitors of carbonic anhydrase for treating glaucoma or ocular hypertension
06/26/2008WO2008075150A1 O-substituted-dibenzyl urea-derivatives as trpv1 receptor antagonists
06/26/2008WO2008075149A2 Ophthalmic compositions of parasympathetic stimulants and anti-inflammatories for use in the treatment of presbyopia
1 ... 3201 3202 3203 3204 3205 3206 3207 3208 3209 3210 3211 3212 3213 3214 3215 3216 3217 3218 3219 3220 3221 ... 7860